参考文献/References:
[1] Heitzer T,Schlinzig T,Krohn K,et al.Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease[J].Circulation,2001,104(22):2673-2678.
[2] Hilgendorf I,Swirski FK,Robbins CS.Monocyte fate in atherosclerosis[J].Arterioscler Thromb Vasc Biol,2015,35(2):272-279.
[3] Nozawa N,Hibi K,Endo M,et al.Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction[J].Circ J,2010,74(7):1384-1391.
[4] Jaipersad AS,Lip GY,Silverman SA.The role of monocytes in angiogenesis and atherosclerosis[J].J Am Coll Cardiol,2014,63(1):1-11.
[5] 于永福,王岚峰.单核细胞/高密度脂蛋白比值与行急诊PCI的STEMI患者院内主要不良心血管事件的相关分析[J].中国循证心血管医学杂志,2017,8(8):963-965.
[6] Rasoul S,Ottervanger JP,De Boer MJ,et al.Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction[J].Coron Artery Dis,2009,20(6):415-421.
[7] Hafiane A,Genest J.High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk[J].BBA CLINICAL,2015,3(1):175-188.
[8] Karabacak M,Kahraman F,Sert M,et al.Increased plasma monocyte chemoattractant protein-1 levels in patients with isolated low high-density lipoprotein cholesterol[J].Scand J Clin Lab Invest,2015,75(4):327-332.
[9] Murphy AJ,Woollard KJ,Hoang A,et al.High-density lipoprotein reduces the human monocyte inflammatory response[J].Arterioscler Thromb Vasc Biol,2008,28(11):2071-2077.
[10] Breton CV,Yin F,Wang XH,et al.HDL anti-oxidant function associates with LDL level in young adults[J].Atherosclerosis,2014,232(1):165-170.
[11] Murphy AJ,Akhtari M,Tolani S,et al.ApoE regulates hematopoietic stem cell proliferation, monocytosis,and monocyte accumulation in atherosclerotic lesions in mice[J].J Clin Invest,2011,121(10):4138-4149.
[12] Van De Woestijne AP,Van Der Graaf Y,Liem AH,et al.Low highdensity lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication[J].J Am Coll Cardiol,2013,62(20):1834-1841.
[13] Kundi H,Kiziltunc E,Cetin M,et al.Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease[J].Herz,2016,41(6):523-529.
[14] Canpolat U,Çetin EH,Cetin S,et al.Association of Monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation[J].Clin Appl Thromb Hemost,2016,22(5):476-482.
[15] Libby P.Inflammation in atherosclerosis[J].Arterioscler Thromb Vasc Biol,2002,420(6917):868-874.
[16] 黄朝发,李菊香,颜素娟,等.单核细胞/高密度脂蛋白胆固醇比值与急性心肌梗死患者介入术后慢血流或无复流的相关性分析[J].中国循环杂志,2017,32(8):737-741.
[17] Cetin MS,Ozcan Cetin EH,Kalender E,et al.Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome[J].Heart Lung Circ,2016,25(11):1077-1086.
[18] Çiçek G,Kundi H,Bozbay M,et al.The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI[J].Coron Artery Dis,2016,27(3):176-184.
[19] Cetin EH,Cetin MS,Canpolat U,et al.Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J].Biomark Med,2015,9(10):967-977.
[20] 张琼瑶,李莉.单核细胞/高密度脂蛋白胆固醇比值与心脏X综合征的相关性分析[J].临床急诊杂志,2017,18(11):823-825, 829.
[21] 陈洁霞,李结华,唐海沁.单核细胞与高密度脂蛋白比值和颈动脉粥样硬化斑块稳定性的相关性研究[J].中国临床保健杂志,2017,20(4):383-385.